Nika Pharmaceuticals, Inc. engages in the development and distribution of various pharmaceutical products. It develops dietary supplements and antiviral drugs; and thymus nuclear glycoprotein (TNG) for the treatment of HIV. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.